Research map: The chemokine network in triple-negative breast cancer: its role in immune microenvironment regulation, and prospects for targeted therapy

Back to the article

Papers in this map

Dendritic cells and the control of immunity · Jacques Banchereau · 1998 · 14448 citations · Cited by this paper
A Latent Inflammatory Tissue-State Variable Mechanistically Links Radiotherapy-Induced Immune Remodeling to Recurrent Tumor Permissiveness · McKenzie A. Mayeaux · 2026 · Cites this paper
A review of soluble mediator and cytokine networks linking combination immunotherapy, tumor microenvironment remodeling and skeletal muscle dysfunction · 2026 · Related
Prospective identification of tumorigenic breast cancer cells · Muhammad Al‐Hajj · 2003 · 10470 citations · Cited by this paper
GFI1 as a novel regulator of γδ T cell development and the IL-17/IFN-γ lineage commitment · 2026 · Related
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells · Sendurai A. Mani · 2008 · 8834 citations · Cited by this paper
HIF-1α-centered metabolic reprogramming in osteoarthritis: cell type-specific effects and intercellular crosstalk among chondrocytes, BMSCs, and macrophages · 2026 · Related
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies · Brian David Lehmann · 2011 · 5674 citations · Cited by this paper
Acquired immune-mediated thrombotic thrombocytopenic purpura with severe cholestatic liver injury and reversible acute kidney injury after ivonescimab-containing chemoimmunotherapy: a case report and literature review · 2026 · Related
The biology and function of fibroblasts in cancer · Raghu K. Kalluri · 2016 · 4479 citations · Cited by this paper
Lipoprotein (a) fuels EV71 replication by activating p38 MAPK-autophagy axis · 2026 · Related
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. · Marco Baggiolini · 1989 · 1996 citations · Cited by this paper
Delivery platforms for in vivo CAR-T engineering · 2026 · Related
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection · Brian David Lehmann · 2016 · 1466 citations · Cited by this paper
Envafolimab – novel anti-PD-1/PD-L1 antibody in cancer treatment · 2026 · Related
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer · Matthew D. Burstein · 2014 · 1437 citations · Cited by this paper
Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma · 2026 · Related
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES · Thomas J. Schall · 1990 · 1407 citations · Cited by this paper
Cancer-associated adipomes promote invadopodia formation and enhance metastatic potential in triple-negative breast cancer. · 2025 · Related
Molecular Definition of Breast Tumor Heterogeneity · Michail V. Shipitsin · 2007 · 1364 citations · Cited by this paper
Inhibition of Interleukin-8/C-X-C Chemokine Receptor 2 Signaling Axis Prevents Tumor Growth and Metastasis in Triple-Negative Breast Cancer Cells · 2025 · Related
Decisions About Dendritic Cells: Past, Present, and Future · Ralph M. Steinman · 2012 · 1275 citations · Cited by this paper
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature · Emmanuelle Charafe‐Jauffret · 2009 · 1181 citations · Cited by this paper
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity · Patrick K. Dorr · 2005 · 1162 citations · Cited by this paper
Global patterns and trends in breast cancer incidence and mortality across 185 countries · Joanne Kim · 2025 · 1125 citations · Cited by this paper
Chemokines and Cell Migration in Secondary Lymphoid Organs · Jason G. Cyster · 1999 · 1037 citations · Cited by this paper
Chemokines and the immune response to cancer · Aleksandra J. Ozga · 2021 · 863 citations · Cited by this paper
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer · Yuanyuan Zhang · 2021 · 821 citations · Cited by this paper
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis · Shicheng Su · 2014 · 800 citations · Cited by this paper
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung · Zvi Granot · 2011 · 800 citations · Cited by this paper
The cytokine network · Frances R. Balkwill · 1989 · 784 citations · Cited by this paper
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts · Christophe Ginestier · 2010 · 753 citations · Cited by this paper
Biology of the rantes/sis cytokine family · Thomas J. Schall · 1991 · 683 citations · Cited by this paper
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4 · Jan Korbecki · 2020 · 481 citations · Cited by this paper
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype · Konrad R. Gabrusiewicz · 2016 · 465 citations · Cited by this paper
Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines · Stephen D. Wolpe · 1989 · 428 citations · Cited by this paper
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8 · Zachary C. Hartman · 2013 · 425 citations · Cited by this paper
CCL5/CCR5 axis in human diseases and related treatments · Zhen Zeng · 2021 · 422 citations · Cited by this paper
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands · Jan Korbecki · 2020 · 396 citations · Cited by this paper

Source: OpenAlex (CC0)